Skip to the content
logo mainlogo darklogo light
  • Home
  • About
  • Platform
  • Cultivation Practices
  • Therapeutics
  • Investors
  • Company News
Get In Touch
logo main
  • Home
  • About
  • Production
  • Cultivation Practices
  • Brands
  • Investors
  • Company News
  • Get In Touch

Author: Jonathan Millbank

06
Aug
CINV

Spotlight on Rheumatoid Arthritis:

What causes Rheumatoid Arthritis (RA) and what is the difference between Osteoarthritis (OA) and Rheumatoid Arthritis? Rheumatoid arthritis (RA) is an autoimmune disorder that caus

Read More
Share
  • Company News
  • Contact
+44 (0)203 1481 452
[email protected]
CINV consolidates regulated plant-derived medicine into a vertically controlled, GMP-aligned platform designed to produce standardised APIs, branded formulations, and clinically governed therapeutics. Medical cannabis provides the commercial foundation. Sceletium and adjacent neuroactive botanicals provide expansion. Pharmaceutical-grade infrastructure creates long-term value.

    Contact us:
    [email protected]
    +44 (0)203 1481 452
    Our address:
    CINV

    3773 Howard Hughes Parkway Suite, 500S, Las Vegas, 89169

    London, 3rd Floor, 86-90 Paul Street, London EC2A 4NE

    Our social:
    Terms and conditions
    Privacy policy

    © 2023 CINV Corp

    [email protected]